Ohio Woman Sues Mylan for Price Gouging in New Lawsuit over EpiPen Price Increase
the latest challenge to the company after nine-year price hikes
In Ohio, Mylan Pharmaceuticals is allegedly violating the state's price-gouging laws over the company's nine-year price increase on EpiPens.
Linda Bates, whose son has severe allergies that require him to carry the medical device, has decided to take the company to court for the price hike from less than $100 (when Mylan bought the EpiPen from Merck) in 2007 to more than $600 in 2016. She has deemed the price hike "outrageous, unconscionable and immoral."
Even with the company agreeing to make a generic version, Bates' lawsuit also alleges that the price increases are in violation with the Ohio Consumer Sales Practices Act, which forbids "unconscionable" acts in consumer transactions, like taking advantage of a consumer's "physical infirmities".
The public response to the lawsuit is "unbelievable", says Carl Lewis, the lawyer representing Linda Bates.
Lewis, told Fox Business News, "We have probably close to 1,000 people that have reached out to us. Social media is unbelievable. Facebook, Twitter. It's been blowing up. I thought it would just be Ohio but it's all over the country".
Lawmakers on both the state and federal levels have been calling on Mylan to lower the price, with some asking for help of Congress, if Mylan decides not to do so voluntarily.